Table 5.
Pre-implant characteristics of patients with no tricuspid valve procedure vs. with tricuspid valve repair for categorical variables.
| Pre-implant Characteristics | No TV procedure Percent n=757 | TV repair Percent n=215 | P-value |
|---|---|---|---|
| Male | 78.2 | 83.3 | 0.11 |
| White | 70.8 | 71.6 | 0.81 |
| Married | 67.7 | 67.1 | 0.88 |
| College | 49.1 | 53.6 | 0.30 |
| Diabetes | 23.9 | 24.2 | 0.94 |
| Inotropes | 84.1 | 81.8 | .042 |
| Ascites | 8.2 | 12.4 | 0.07 |
| COPD | 10.7 | 7.6 | .019 |
| INTERMACS Patient Profile Level 1: Critical Cardiogenic Shock | 9.8 | 9.8 | 1.00 |
| INTERMACS Patient Profile Level 2: Progressive Decline | 38.0 | 44.7 | 0.08 |
| INTERMACS Patient Profile Level 3 | 33.7 | 28.8 | 0.18 |
| INTERMACS Patient Profile Level 4 | 12.8 | 13.0 | .094 |
| INTERMACS Patient Profile Level 5 | 3.8 | 2.8 | 0.47 |
| INTERMACS Patient Profile Level 6 | 0.9 | 0.9 | 0.99 |
| INTERMACS Patient Profile Level 7 | 0.9 | 0.0 | 0.16 |
| NYHA = 4 | 82.6 | 84.0 | 0.64 |
| Coronary artery disease | 6.6 | 2.3 | 0.02 |
| Cerebrovascular accident | 4.7 | 5.2 | 0.75 |
| Transient ischemic attack | 3.4 | 1.0 | 0.06 |
| Cancer | 8.4 | 8.6 | 0.92 |
| Current smoker | 6.1 | 6.3 | 0.94 |
| Current drug abuse | 0.8 | 1.9 | 0.18 |
| Alcohol abuse | 9.7 | 7.3 | 0.29 |
| Blood Type O | 44.2 | 38.6 | 0.15 |
| Rheumatologic disease | 3.7 | 5.5 | 0.41 |
| Hepatitis B | 1.2 | 1.0 | 0.82 |
| Hepatitis C | 2.8 | 2.9 | 0.93 |
| Dialysis | 1.3 | 2.3 | 0.29 |
| History of coronary artery bypass | 32.5 | 29.3 | 0.37 |
| History of Valve Surgery | 9.6 | 10.7 | 0.65 |
| Implantable cardioverter defibrillator | 87.8 | 90.6 | 0.27 |
| Intra-aortic balloon pump | 22.2 | 33.0 | 0.11 |
| Ventilator | 3.7 | 1.9 | 0.18 |
| Peripheral vascular disease | 7.9 | 10.0 | 0.47 |
| Carotid artery disease | 11.7 | 13.6 | 0.59 |
| β-Blockers | 78.1 | 74.9 | 0.32 |
| Angiotensin-converting-enzyme inhibitor | 47.2 | 42.6 | 0.26 |
| Mitral regurgitation (Moderate/Severe) | 77.4 | 75.0 | 0.47 |
| Aortic regurgitation (Moderate/Severe) | 6.5 | 7.1 | 0.77 |
| Left ventricular ejection fraction (< 20 %) | 71.2 | 71.0 | 0.97 |
| Right ventricular ejection fraction (severely reduced) | 21.1 | 24.5 | 0.39 |
| Failure to wean | 0.9 | 1.9 | 0.18 |
| Extracorporeal membrane oxygenation | 0.4 | 1.4 | 0.10 |
| Patient Profile Modifier TCS | 17.7 | 20.7 | 0.36 |
COPD, chronic obstructive pulmonary disease; Failure to wean, inability to wean from cardiopulmonary bypass during other cardiac surgical procedure; INTERMACS, Interagency Registry for Mechanically Assisted Circulatory Support; NYHA, New York Heart Association; TCS, temporary circulatory support; TV, tricuspid valve.